All — ST PHARM

Science & Technology
- Business Overview
- CDMO
- CRO
  - AnaPath Research & Service
- R&D
  - Virtual R&D
  - Global R&D
About
Public
- PR (Public Relations)
  - News room
- IR (Investor Relations)
  - Stock Information
  - IR Library
Careers
ESG

Linkedin

Public

All

PR (Public Relations)
- News room
IR (Investor Relations)
- Stock Information
- IR Library

ST PHARM's Public Release

ST PHARM News'100-Day Expedite Strategy', Preparedness and Proactive Measures for Future PandemicNov 21, 2023

ST PHARM News'To Become a Global Korean CDMO' - 2023 Economic Daily Pharmaceutical Bio ForumNov 21, 2023

ST PHARM NewsInvesting in mRNA platforms to create CDMO-biotech partnership opportunitiesNov 13, 2023

ST PHARM NewsVisit of the International Vaccine Institute (IVI) Board of Trustees at ST PharmNov 9, 2023

ST PHARM News[ST Pharm Leaflet] Small MoleculeOct 31, 2023

ST PHARM News[ST Pharm Leaflet] Generic APIOct 31, 2023

ST PHARM News[ST Pharm Leaflet] MonomerOct 31, 2023

ST PHARM News[ST Pharm Leaflet] Oligonucleotide CDMOOct 31, 2023

ST PHARM News[ST Pharm Leaflet] mRNA CDMO (SmartCap® STLNP®)Oct 31, 2023

ST PHARM NewsST Pharm Upcoming EventsOct 15, 2023

ST PHARM NewsST Pharm breaks ground on 2nd State-of-the-Art Oligonucleotide FacilitySep 19, 2023

ST PHARM News[Inovation Center Time lapse Movie]Mar 6, 2023

Media FocusST PHARM Cuts Joint Research Deal with Multiverse Pharma in the U.S.Feb 24, 2023

1of4